Updated:
ALIVE
Alive is one of Israel's leading HealthTech investment platforms, backing advanced-stage MedTech, Digital Health and Bio-convergence companies ready to scale,...
ALIVE
Alive is one of Israel's leading HealthTech investment platforms, backing advanced-stage MedTech, Digital Health and Bio-convergence companies ready to scale, commercialize, and lead global markets. Since inception in 2020, Alive has launched 3 funds. Its funds include a 2020 vintage HealthTech fund with more than $110M AUM and a growth fund dedicating about $200M AUM to growth-stage investments.
General information
Firm type
Venture Capital
Year founded
2018
Location
Region
Middle East
Country
Israel
City
Bogotá
Corporate office
Israel
Principals
Prof. Ari Shamiss
Co-Founder & General Partner
Prof. Rafael Beyar
Co-Founder & General Partner
Michel Habib
Co-Founder & Managing General Partner
Dudi Klein
Co-Founder & Managing General Partner
Zeev Zehavi
Senior Advisor Member, Investment Committee
Noy Hoffman
Investment Associate
Shir Bernstein
Operations Manager
Iris Beck
Board Observer Member, Investment Committee
Jonathan Cohen
Principal
Luba Ilfeld
Investment Associate
Sector focus
Frequently asked questions
Is ALIVE structured as a venture capital firm or a venture studio?
ALIVE blends characteristics of both models. It operates as a venture capital firm deploying external capital, but its multi-stage, hands-on approach resembles a venture studio that remains closely involved with portfolio companies across their lifecycle. Without disclosed team bios or portfolio specifics, the exact operational model remains a matter of inference based on its stated co-investment and stage-spanning mandate.
Does ALIVE invest only in Israel?
Based on public record, ALIVE's primary geographic focus is Israel, where it is headquartered. There is no confirmation of additional offices or a formal mandate to invest outside the country. Israeli venture firms of ALIVE's profile often concentrate domestically given the density of deal flow in sectors like cybersecurity, enterprise software, and AI infrastructure.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: